Clinical Trial

Inflammation and Diabetes: Evaluating Antioxidant Levels

Study acronym: IDEAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational, cross-sectional study is to evaluate the relationships between dietary total antioxidant capacity, systemic inflammatory response markers, and nutritional parameters in adult patients with Type 2 Diabetes (T2DM). Participants will be classified into controlled (HbA1c \< %7) and uncontrolled (HbA1c ≥ %7) diabetes groups based on their glycemic control. The main questions it aims to answer are: Does dietary antioxidant capacity affect systemic inflammation levels and metabolic parameters? Is there a relationship between nutritional risk status and inflammatory response in T2DM patients?
Trial Details
NCT Number NCT07734428
Lead Sponsor Istanbul Bilgi University
Collaborators: İstanbul Gaziosmanpaşa Training and Research Hospital
Conditions Diabete Mellitus, Diabete Type 2, Inflamation, Systemic Inflammation, Dietary Inflammatory Index (DII), Systemic Inflammation Markers
Enrollment 180 participants
Start Date 2026-07-15
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-29